首页|期刊导航|中华医学杂志（英文版）|Immune-related genetic prognostic index to predict prognosis and immune checkpoint inhibitor therapy efficiency in acute myeloid leukemia

Immune-related genetic prognostic index to predict prognosis and immune checkpoint inhibitor therapy efficiency in acute myeloid leukemia

Xunhong Cao Xiaojun Huang Xiangyu Zhao

中华医学杂志（英文版）2023，Vol.136Issue(10)：1253-1255,3.

中华医学杂志（英文版）2023，Vol.136Issue(10)：1253-1255,3.DOI:10.1097/CM9.0000000000002657

Immune-related genetic prognostic index to predict prognosis and immune checkpoint inhibitor therapy efficiency in acute myeloid leukemia

Xunhong Cao ¹Xiaojun Huang ¹Xiangyu Zhao¹

作者信息

1. Peking University People's Hospital,Peking University Institute of Hematology,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation,National Clinical Research Center for Hematologic Disease,Beijing 100044,China
折叠

摘要

引用本文复制引用

Xunhong Cao,Xiaojun Huang,Xiangyu Zhao..Immune-related genetic prognostic index to predict prognosis and immune checkpoint inhibitor therapy efficiency in acute myeloid leukemia[J].中华医学杂志（英文版）,2023,136(10):1253-1255,3.

基金项目

This study was supported by grants from the National Natural Science Foundation of China(Nos.81670166,81870140,82070184,and 81621001),Peking University People's Hospital Research and Development Funds(No.RDL2021-01),Beijing Life Oasis Public Service Center(No.CARTFR-01),and CSH Young Scholars and 3SBio Pharmaceutical joint research project(No.KYC2201001). （Nos.81670166,81870140,82070184,and 81621001）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINE

ISSN：0366-6999

访问量0

下载量0

段落导航